301130 Stock Overview
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd engages in the research and development, production, and sale of chemical raw materials and pharmaceutical preparations in China.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥26.42 |
| 52 Week High | CN¥36.00 |
| 52 Week Low | CN¥15.20 |
| Beta | 0.60 |
| 1 Month Change | 9.90% |
| 3 Month Change | 48.18% |
| 1 Year Change | -2.15% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -53.66% |
Recent News & Updates
Shareholder Returns
| 301130 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 4.7% | 3.1% | 0.9% |
| 1Y | -2.1% | -6.2% | -11.3% |
Return vs Industry: 301130 exceeded the CN Pharmaceuticals industry which returned -6.2% over the past year.
Return vs Market: 301130 exceeded the CN Market which returned -11.3% over the past year.
Price Volatility
| 301130 volatility | |
|---|---|
| 301130 Average Weekly Movement | 6.4% |
| Pharmaceuticals Industry Average Movement | 6.1% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in CN Market | 11.1% |
| 10% least volatile stocks in CN Market | 4.3% |
Stable Share Price: 301130's share price has been volatile over the past 3 months.
Volatility Over Time: 301130's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 269 | Jun Zhang | xidianyy.com |
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd engages in the research and development, production, and sale of chemical raw materials and pharmaceutical preparations in China. The company provides drugs for the treatment of anemia, mental disorders, cardiovascular and cerebrovascular diseases, and tumors. It provides drugs in the form of tablets and capsules.
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Fundamentals Summary
| 301130 fundamental statistics | |
|---|---|
| Market cap | CN¥2.06b |
| Earnings (TTM) | CN¥54.97m |
| Revenue (TTM) | CN¥236.76m |
37.5x
P/E Ratio8.7x
P/S RatioIs 301130 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301130 income statement (TTM) | |
|---|---|
| Revenue | CN¥236.76m |
| Cost of Revenue | CN¥49.62m |
| Gross Profit | CN¥187.13m |
| Other Expenses | CN¥132.16m |
| Earnings | CN¥54.97m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.70 |
| Gross Margin | 79.04% |
| Net Profit Margin | 23.22% |
| Debt/Equity Ratio | 0% |
How did 301130 perform over the long term?
See historical performance and comparison